CLINICAL_TRIALS
trial_result
· 2011-10-05
Clinical Trial Update: Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
Summary
Phase III trial of CUV1647 for polymorphic light eruption has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Polymorphic Light Eruption (PLE) | Status: COMPLETED